Dasatinib in Relapsed Chronic Lymphocytic Leukemia

Clinical trial NCT00438854 · COMPLETED

Trial details

NCT number: NCT00438854
Sponsor: Massachusetts General Hospital
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Chronic Lymphocytic Leukemia

Start date: 2006-12-01
Primary completion: 2010-10-01
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.